Search

Your search keyword '"Afşar, Bilgen Begüm"' showing total 2 results
Start Over Author "Afşar, Bilgen Begüm" Topic smoking
2 results on '"Afşar, Bilgen Begüm"'

1. İki Büyük Halk Sağlığı Sorununun Birlikteliği: Sigara ve Tüberküloz

Author

YALÇINSOY, Murat, GÜNGÖR, Sinem, AFŞAR, Bilgen Begüm, BAĞCI, Belma Akbaba, SELÇUK, Engin Burak, and AKKAYA, Esen

Subjects
Tuberculosis, Smoking, Risk Factors, Tüberküloz, Sigara, Risk Faktörleri
Abstract

Tobacco smoking and tuberculosis (TB) are two both of the world's greatest public health problems. Even though risk factors of TB well defined, association between smoking and TB is still a matter of debate and controversy. In recent studies have summarized a large body of published literature on the association between smoking and various TB outcomes produced evidence that smoking is a risk factor for TB infection and TB disease. In majority of these studies smoking causes additional mortality risk. Active TB disease treatment is not enough anymore. Convertible risk factors such as smoking are new viewpoint. World Health Organization (WHO) set up TB control programs with control from critical and preventable risk factors as smoking and alcoholism within a Directly Observed Treatment Strategy-based (DOTS) programme. Key words: Tuberculosis; Smoking; Risk Factors., Günümüzde sigara kullanımı ve tüberküloz (TB) önemli iki halk sağlığı sorunudur. TB gelişiminde risk faktörleri iyi tanımlanmış olmakla birlikte sigaranın yeri hep tartışmalı kalmıştır. Son yıllarda yapılan çalışmalarda sigara içiminin TB enfeksiyonu, aktif TB gelişimi ve mortaliteye etkisi araştırılmış, sigaranın TB enfeksiyonu ve aktif TB gelişimini etkilediği, tartışmalı olmakla birlikte yayınların pek çoğunda da mortaliteyi arttırdığı sonucuna varılmıştır. Günümüzde, aktif hastalığın tedavisinin, tek başına yeterli olmadığının gösterilmesi ile değiştirilebilir risk faktörlerinin tedavideki yeri; örneğin sigara kullanımının bırakılması, yeni bakış açısı oluşturmuştur. Dünya sağlık örgütü (DSÖ) gelecekteki tüberküloz kontrol programlarını, direkt gözlem altında tedavi (DGT) uygulamaları yanı sıra sigara ve alkol gibi tehlikeli ama önlenebilir davranışsal risk faktörlerinden korunmayı da içerecek şekilde hazırlamaktadır. Anahtar kelimeler: Tüberküloz; Sigara; Risk Faktörleri.

Published
2015

2. Success Rates of Pharmacological Therapies Used for Smoking Cessation and Factors that Affect Smoking Cessation Rates.

Author

Tanrıverdi, Hakan, Altuntaş, Murat, Demir, Özgür, Afşar, Bilgen Begüm, and Çelikiz, Metin

Subjects
*CARBON monoxide analysis, *ACADEMIC medical centers, *BLOOD testing, *CHI-squared test, *PATIENT monitoring, *PUBLIC health surveillance, *SMOKING, *SMOKING cessation, *T-test (Statistics), *TREATMENT effectiveness, *RETROSPECTIVE studies, *DATA analysis software, *DESCRIPTIVE statistics, *ODDS ratio
Abstract

Smoking is still the most important cause of preventable diseases and premature deaths. Thus, smoking cessation interventions should include pharmacological therapies and/or counseling either alone or in combination. To analyze the demographic data of patients who presented to the smoking cessation polyclinic and received pharmacological therapies and determine the success rate of given therapies, and the factors that affect smoking cessation rates retrospectively. This retrospective study included patients who presented to the smoking cessation polyclinic and received pharmacological therapy (varenicline, bupropion or nicotine replacement therapy). Demographic data of patients, exhaled carbonmonoxide levels, and Fagerström test for nicotine addiction results were derived. Patients were reached by telephone survey in February 2013, and asked for their current smoking status and duration of therapy at the end of therapy. Patients were grouped into quitters and non-quitters. Differences between groups were assessed, and success rates of pharmacological therapies were compared. The study included 240 women and 509 men. Fagerström test for nicotine addiction results and exhaled carbonmonoxide levels were statistically higher in the non-quitter group than the quitter group. We did not find any significant difference between the groups in variables such as profession, age, gender, marital status and education levels. Varenicline had the highest smoking cessation rates at the end of therapy, and the rates were significantly different from others. Smoking cessation rates for varenicline, bupropion and nicotine replacement therapy were 50.9%, 35.9%, and 35.2%, respectively (p<0,05). However, long-term success rates (3-12 months) were similar for all pharmacotherapies. Long-term success rates of pharmacological interventions used for smoking cessation were not significantly different among groups. To prevent relapses, patients should be monitorized closely and new interventions should be developed to keep patients' motivation high for long-term abstinence. [ABSTRACT FROM AUTHOR]

Published
2015
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results